{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:34:03Z","timestamp":1781019243771,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40121-020-00305-6","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T14:02:35Z","timestamp":1590847355000},"page":"589-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev\u00ae) in South Korea, 2015\u20132019"],"prefix":"10.1007","volume":"9","author":[{"given":"Hee Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongho","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Korejwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie Bosch","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuhyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"issue":"2","key":"305_CR1","first-page":"257","volume":"26","author":"YH Hong","year":"2014","unstructured":"Hong YH. Japanese encephalitis in South Korea. Sh\u014dni Kansen Men'eki. 2014;26(2):257\u201362.","journal-title":"Sh\u014dni Kansen Men'eki"},{"issue":"6","key":"305_CR2","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1016\/j.ijid.2012.02.006","volume":"16","author":"DW Lee","year":"2012","unstructured":"Lee DW, Choe YJ, Kim JH, Song KM, Cho H, Bae GR, et al. Epidemiology of Japanese encephalitis in South Korea, 2007\u20132010. Int J Infect Dis. 2012;16(6):e448\u2013e45252. https:\/\/doi.org\/10.1016\/j.ijid.2012.02.006.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"305_CR3","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3201\/eid2210.160288","volume":"22","author":"JS Sunwoo","year":"2016","unstructured":"Sunwoo JS, Jung KH, Lee ST, Lee SK, Chu K. Reemergence of Japanese encephalitis in South Korea, 2010\u20132015. Emerg Infect Dis. 2016;22(10):1841\u20133. https:\/\/doi.org\/10.3201\/eid2210.160288.","journal-title":"Emerg Infect Dis"},{"key":"305_CR4","unstructured":"World Health Organization. Immunization coverage or administered doses. 2019. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/en\/. Accessed 24 Feb 2020."},{"key":"305_CR5","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system (2019 global summary). Incidence time series for Republic of Korea. 2019. https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/incidences?c=KOR. Accessed 24 Feb 2020."},{"issue":"6","key":"305_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1080\/21645515.2017.1285472","volume":"13","author":"NR Hegde","year":"2017","unstructured":"Hegde NR, Gore MM. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum Vaccin Immunother. 2017;13(6):1320\u201337. https:\/\/doi.org\/10.1080\/21645515.2017.1285472.","journal-title":"Hum Vaccin Immunother"},{"key":"305_CR7","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (ICH-E2A). 1995. https:\/\/www.fda.gov\/media\/71188\/download. Accessed 24 Feb 2020."},{"issue":"6","key":"305_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/INF.0000000000000276","volume":"33","author":"E Feroldi","year":"2014","unstructured":"Feroldi E, Pancharoen C, Kosalaraksa P, Chokephaibulkit K, Boaz M, Meric C, et al. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J. 2014;33(6):643\u20139. https:\/\/doi.org\/10.1097\/INF.0000000000000276.","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"305_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4161\/hv.20071","volume":"8","author":"E Feroldi","year":"2012","unstructured":"Feroldi E, Pancharoen C, Kosalaraksa P, Watanaveeradej V, Phirangkul K, Capeding MR, et al. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12\u201318 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother. 2012;8(7):929\u201337. https:\/\/doi.org\/10.4161\/hv.20071.","journal-title":"Hum Vaccin Immunother"},{"issue":"50","key":"305_CR10","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","volume":"28","author":"J Torresi","year":"2010","unstructured":"Torresi J, McCarthy K, Feroldi E, Meric C. Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials. Vaccine. 2010;28(50):7993\u20138000. https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.035.","journal-title":"Vaccine"},{"issue":"12","key":"305_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","volume":"29","author":"K Chokephaibulkit","year":"2010","unstructured":"Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, Sabchareon A, Pancharoen C, Bouckenooghe A, et al. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J. 2010;29(12):1111\u20137. https:\/\/doi.org\/10.1097\/INF.0b013e3181f68e9c.","journal-title":"Pediatr Infect Dis J"},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijid.2017.10.010","volume":"66","author":"TD Vu","year":"2018","unstructured":"Vu TD, Nguyen QD, Tran HTA, Bosch-Castells V, Zocchetti C, Houillon G. Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: a single-arm, single-center study. Int J Infect Dis. 2018;66:137\u201342. https:\/\/doi.org\/10.1016\/j.ijid.2017.10.010.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"305_CR13","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.4161\/hv.29743","volume":"10","author":"DS Kim","year":"2014","unstructured":"Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, et al. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea. Hum Vaccin Immunother. 2014;10(9):2656\u201363. https:\/\/doi.org\/10.4161\/hv.29743.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"305_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.vaccine.2016.11.062","volume":"35","author":"T Chotpitayasunondh","year":"2017","unstructured":"Chotpitayasunondh T, Pruekprasert P, Puthanakit T, Pancharoen C, Tangsathapornpong A, Oberdorfer P, et al. Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand. Vaccine. 2017;35(2):299\u2013304. https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.062.","journal-title":"Vaccine"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-020-00305-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-020-00305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:29:38Z","timestamp":1715668178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-020-00305-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1007\/s40121-020-00305-6","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}